Co-founder and Director of Research and Development, Infinity Bio
BIOGRAPHY
Date: October 1, 2024 | Time: 7:00 AM PDT, 9:00 AM CDT, 10:00 AM EDT
Unveiling the Antibody Reactome: A New Frontier in Precision Immunology
Speaker
Event Date & Time
Date: October 1, 2024
Time: 7:00 AM PDT, 9:00 AM CDT, 10:00 AM EDT
Abstract
The human antibody repertoire, or reactome, is a vast and dynamic network of antibody-antigen interactions that plays a crucial role in health and disease. Understanding the complexity of this network is key to unlocking novel understanding of disease etiologies, new diagnostics, therapeutics, and personalized medicine approaches. In this webinar, Infinity Bio will showcase its cutting-edge technology for high-resolution antibody reactome profiling. We will delve into how this technology can provide unprecedented insights into the immune system's response to various diseases, including infectious diseases, autoimmune disorders, and allergies.
Key takeaways:
- Discover Infinity Bio's next-generation antibody profiling assay, capable of capturing the full spectrum of antibody diversity with unmatched depth, precision and speed.
- Explore real-world applications of this technology in
- Biomarker discovery and patient stratification for health and disease research
- Monoclonal antibody characterization: Target identification, cross-reactivity and sensitivity.
- Learn how Infinity Bio's technology can transform our understanding of the immune system and pave the way for a new era of precision immunology.
Agenda
- Intro of Joel Credle, PhD., Co-founder & Director of R&D
- Infinity Bio company introduction
- Significance and importance of antibody reactome profiling in human research
- Our MIPSA technology, a next-gen antigen display tool
- Automating MIPSA Assay: Confidence in the answers
- Applications:
- High Throughput Serology: The power of cohorts in translational research
- Monoclonal Antibodies: Developing Therapeutic mAbs at scale
- Q&A
Join us for this exciting webinar and learn how Infinity Bio is revolutionizing the field of antibody profiling and its application to health and disease.
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Loading Comments...